方盛制药
(603998)
| 流通市值：45.97亿 | | | 总市值：45.97亿 |
| 流通股本：4.39亿 | | | 总股本：4.39亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 187,229,940.96 | 308,459,619.06 | 195,447,028 | 202,057,676.08 |
| 应收票据及应收账款 | 291,335,868.67 | 250,238,940.62 | 283,284,810.38 | 288,603,923.55 |
| 应收账款 | 291,335,868.67 | 250,238,940.62 | 283,284,810.38 | 288,603,923.55 |
| 应收款项融资 | 29,352,532.07 | 35,077,930.55 | 27,701,847.37 | 16,504,870.1 |
| 预付款项 | 56,173,516.04 | 63,077,175.67 | 77,193,899.16 | 101,031,923.76 |
| 其他应收款合计 | 16,341,624.98 | 37,874,917.18 | 48,759,429.49 | 19,458,896.87 |
| 存货 | 386,402,643.19 | 376,151,516.76 | 384,096,904.92 | 374,873,126.41 |
| 一年内到期的非流动资产 | 23,529,411.76 | 53,393,665.15 | - | - |
| 其他流动资产 | 16,700,997.53 | 13,265,367.25 | 11,735,385.68 | 11,951,517.51 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,007,066,535.2 | 1,137,539,132.24 | 1,044,743,627.41 | 1,029,934,537.28 |
| 非流动资产: | | | | |
| 长期应收款 | 48,514,047.28 | 47,530,066.55 | 142,285,733.27 | 139,957,909.49 |
| 长期股权投资 | 238,124,727.78 | 239,099,437.15 | 241,439,091.05 | 247,530,632.06 |
| 其他权益工具投资 | 3,000,000 | - | - | - |
| 其他非流动金融资产 | - | - | 1 | 1 |
| 投资性房地产 | 69,164,191.42 | 69,592,555.13 | - | 10,289,645.57 |
| 固定资产 | 922,578,101.06 | 829,300,337.39 | 911,195,258.1 | 810,636,219.95 |
| 在建工程 | 175,363,531.54 | 262,364,637.13 | 246,005,664.8 | 290,636,407.7 |
| 使用权资产 | 17,279,526.33 | 17,897,863.17 | 18,516,200.01 | 19,134,536.85 |
| 无形资产 | 277,384,357.72 | 281,591,386.16 | 254,153,789.82 | 258,784,111.84 |
| 开发支出 | - | - | 750,000 | - |
| 商誉 | 269,025,023.36 | 269,025,023.36 | 274,405,463.36 | 274,405,463.36 |
| 长期待摊费用 | 12,792,658.8 | 13,772,775.55 | 14,859,720.54 | 16,455,493.22 |
| 递延所得税资产 | 9,867,251.36 | 10,147,121.8 | 13,820,245.69 | 16,114,070.04 |
| 其他非流动资产 | 99,840,657.24 | 88,713,128.96 | 123,990,273.16 | 113,218,510.15 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,142,934,073.89 | 2,129,034,332.35 | 2,241,421,440.8 | 2,197,163,001.23 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,150,000,609.09 | 3,266,573,464.59 | 3,286,165,068.21 | 3,227,097,538.51 |
| 流动负债: | | | | |
| 短期借款 | 471,558,543.47 | 531,485,901.8 | 541,158,169.45 | 548,824,294.45 |
| 应付票据及应付账款 | 248,444,016.02 | 244,262,402.22 | 270,163,428.99 | 241,438,064.32 |
| 其中：应付票据 | 75,822,027.34 | 62,590,206.42 | 82,968,305.33 | 100,788,802.97 |
| 应付账款 | 172,621,988.68 | 181,672,195.8 | 187,195,123.66 | 140,649,261.35 |
| 预收款项 | 8,577,304.58 | 8,565,701.58 | 682,416.61 | 3,252,491.5 |
| 合同负债 | 20,787,161.66 | 27,656,976.39 | 22,933,121.54 | 25,249,864.03 |
| 应付职工薪酬 | 25,860,921.51 | 44,605,935.45 | 32,750,562 | 22,553,547.65 |
| 应交税费 | 23,295,955.75 | 19,333,359.99 | 24,586,554.78 | 28,347,166 |
| 其他应付款合计 | 410,479,573.72 | 416,226,441.15 | 450,564,253.71 | 452,784,587.21 |
| 一年内到期的非流动负债 | 3,179,798.47 | 3,216,635.42 | 49,666,813.82 | 62,557,434.29 |
| 其他流动负债 | 2,187,980.23 | 3,176,094.16 | 2,389,260 | 2,709,116.04 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,214,371,255.41 | 1,298,529,448.16 | 1,394,894,580.9 | 1,387,716,565.49 |
| 非流动负债: | | | | |
| 长期借款 | 88,992,931.67 | 146,503,415.39 | 97,575,833.34 | 128,101,222.22 |
| 租赁负债 | 18,514,162.55 | 19,042,018.99 | 19,563,864.82 | 20,079,768.37 |
| 长期应付款 | - | - | 200,000 | 200,000 |
| 递延收益 | 35,566,232.73 | 34,056,070.62 | 30,439,299.9 | 31,329,678.46 |
| 递延所得税负债 | 33,070,467.74 | 33,574,212.78 | 32,124,077.27 | 33,201,922.88 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 176,143,794.69 | 233,175,717.78 | 179,903,075.33 | 212,912,591.93 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,390,515,050.1 | 1,531,705,165.94 | 1,574,797,656.23 | 1,600,629,157.42 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 439,081,360 | 439,085,060 | 439,124,060 | 439,124,060 |
| 资本公积 | 169,956,506.35 | 189,628,045.26 | 188,909,207.67 | 187,443,036.68 |
| 减:库存股 | - | 1,002,705 | 1,116,195 | 13,931,295 |
| 其他综合收益 | -74,869.54 | -74,869.54 | -74,869.54 | -74,869.54 |
| 盈余公积 | 157,922,273.99 | 157,922,273.99 | 133,730,977.13 | 133,730,977.13 |
| 未分配利润 | 899,322,881.93 | 837,407,612.08 | 834,474,657.6 | 765,160,171.59 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0.01 | 0 |
| 归属于母公司股东权益合计 | 1,666,208,152.73 | 1,622,965,416.79 | 1,595,047,837.87 | 1,511,452,080.86 |
| 少数股东权益 | 93,277,406.26 | 111,902,881.86 | 116,319,574.12 | 115,016,300.23 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,759,485,558.99 | 1,734,868,298.65 | 1,711,367,411.99 | 1,626,468,381.09 |
| 负债和股东权益合计 | 3,150,000,609.09 | 3,266,573,464.59 | 3,286,165,068.21 | 3,227,097,538.51 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |